During the meeting AISM will give an update on its national and international strategic research initiatives and discuss their potential impact on the ‘Future’ of MS: to slow, stop or reverse the progression of the disease.
AISM will emphasise the need to work together on national and international efforts to speed up the development of innovative therapies and the commitment of the Progressive Multiple Sclerosis Alliance (PMSA).
They will also present ‘Data Sharing’ initiatives and the importance, for the future of MS, to collect and share clinical and MRI data towards a personalized treatment.
- 25th May 2016 - 27th May 2016
- Rome, Italy